Skip to main content
Home
FULL MENU Close Menu
Home
Home

Erik Greb

Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.

News

More than one in six patients with status epilepticus are readmitted after hospital discharge

Author:
Erik Greb

PHILADELPHIA – Identifying patients at high risk of readmission could reduce their financial and clinical burdens....

  • Read More

News

Changes in brain networks may predict MS worsening

Author:
Erik Greb
Publish date: May 9, 2019

PHILADELPHIA – Structural and functional network MRI measures appear to identify patients at high risk for increased...

  • Read More

News

Galcanezumab reduces cluster headache attack frequency

Author:
Erik Greb

PHILADELPHIA – The treatment appears to have the same safety and tolerability in this population as among patients...

  • Read More

News

Cannabidiol reduces seizures in Dravet syndrome

Author:
Erik Greb

PHILADELPHIA – Two dosages of the CBD treatment appear to have similar efficacy, but the lower dose may be more...

  • Read More

News

Researchers examine vitamin D, skin pigmentation, and outcomes of pediatric MS

Author:
Erik Greb

PHILADELPHIA – The association between vitamin D insufficiency and MS outcome in children appears to relate partly...

  • Read More

News

Criterion based on the central vein sign distinguishes between MS and mimics

Author:
Erik Greb
Publish date: May 7, 2019

PHILADELPHIA – Applying the criterion of three lesions with the central vein sign is feasible in clinical practice...

  • Read More

News

Laquinimod may not improve motor function in Huntington’s disease

Author:
Erik Greb
Publish date: May 6, 2019

PHILADELPHIA – The drug raises no new safety concerns in patients with Huntington’s disease, compared with previous...

  • Read More

News

Biomarkers in tears may help identify patients with Parkinson’s disease

Author:
Erik Greb

PHILADELPHIA – Levels of oligomeric alpha synuclein are higher among patients with Parkinson’s disease than among...

  • Read More

News

CSF and plasma biomarkers predict survival in sporadic Creutzfeldt-Jakob disease

Author:
Erik Greb

An analysis suggests the possibility of using a minimally invasive biomarker to guide clinical care and improve clinical trial design.

  • Read More

News

Cluster headache is associated with increased suicidality

Author:
Erik Greb

The short- and long-term disease burden of cluster headache, along with depressive symptoms, contributes to the increased risk of suicidality.

  • Read More

News

Sleep apnea is linked with tau accumulation in the brain

Author:
Erik Greb
Publish date: April 30, 2019

Philadelphia – Study results suggest a mechanism for the observed association between sleep disruption and increased...

  • Read More

News

Does BMI affect outcomes after ischemic stroke?

Author:
Erik Greb

Overweight and obese patients have greater survival and less risk of disability after acute ischemic stroke, according to an analysis of the FAST-...

  • Read More

News

Study finds increase in dermatologic prescriptions for postsurgical antibiotics

Author:
Erik Greb
Publish date: April 25, 2019

WASHINGTON – The investigators observed a greater than twofold variation in antibiotic prescribing rates across...

  • Read More

News

TMS is associated with improved recollection in older adults

Author:
Erik Greb

Behavioral and neural correlates of recollection changed after five sessions of hippocampal-cortical network stimulation, but recognition was...

  • Read More

News

PAP may reduce mortality in patients with obesity and severe OSA

Author:
Erik Greb
Publish date: April 23, 2019

A population-based cohort study has implications for clinical practice, but its results require confirmation in future trials.

  • Read More

Pages

  • « first
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close